Practical constraints with machine learning in drug discovery
نویسندگان
چکیده
منابع مشابه
Drug Discovery by Machine Learning Method
The aim of this work is to create a one-class classification model using the method of support vector clustering and evaluate its usefulness in drug discovery. The one-class classification model is tested on both sonar data and 5-HT2A-binding compound data. From the results, 88.99 % accuracy is obtained for sonar data and 93.269 % testing accuracy is obtained for classification of 5-HT2Abinding...
متن کاملMachine-learning approaches in drug discovery: methods and applications.
During the past decade, virtual screening (VS) has evolved from traditional similarity searching, which utilizes single reference compounds, into an advanced application domain for data mining and machine-learning approaches, which require large and representative training-set compounds to learn robust decision rules. The explosive growth in the amount of public domain-available chemical and bi...
متن کاملApplication of Machine Learning in Drug Discovery and Development
Machine learning techniques have been widely used in drug discovery and development, particularly in the areas of cheminformatics, bioinformatics and other types of pharmaceutical research. It has been demonstrated they are suitable for large high dimensional data, and the models built with these methods can be used for robust external predictions. However, various problems and challenges still...
متن کاملDistributed Machine Learning with Communication Constraints
Distributed Machine Learning with Communication Constraints by Yuchen Zhang Doctor of Philosophy in Computer Science University of California, Berkeley Professor Michael I. Jordan, Co-chair Professor Martin J. Wainwright, Co-chair Distributed machine learning bridges the traditional fields of distributed systems and machine learning, nurturing a rich family of research problems. Classical machi...
متن کاملApplication of Machine Learning in Knowledge Discovery for Pharmaceutical Drug-drug Interactions
Artificial neural networks (ANNs) have been developed to predict the clinical significance of drug-drug interactions (DDIs) for a set of 35 pharmaceutical drugs using data compiled from the Web-based resources, Lexicomp® and Vidal®, with inputs furnished by various drug pharmacokinetic (PK) and/or pharmacodynamic (PD) properties, and/or drug-enzyme interaction data. Success in prediction of DDI...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Opinion on Drug Discovery
سال: 2021
ISSN: 1746-0441,1746-045X
DOI: 10.1080/17460441.2021.1887133